Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients. [electronic resource]
Producer: 20170613Description: 681-688 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Area Under Curve
- Biological Availability
- Capsules
- Cross-Over Studies
- Drug Compounding
- Female
- Humans
- MAP Kinase Signaling System -- drug effects
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Niacinamide -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Tablets
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.